Used in pharmaceutical research as a potent inhibitor of tyrosine kinases, particularly involved in signaling pathways related to cancer cell proliferation and survival. Shows promise in the development of targeted therapies for solid tumors and hematologic malignancies. Its structure allows for high selectivity toward specific kinase domains, improving efficacy and reducing off-target effects in drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of anticancer agents.